obviously difficult to be convinced by such small numbers but there are figures which appear to support the rationale of local treatment (Kottmeier 1968) . At the Radiumhemmet 555 cases have been studied and, although Kottmeier advocates removal of the other ovary, no evidence of carcinoma has been found in an apparently normal ovary. If there was obvious spread at the time of operation, serous carcinoma was involving both ovaries much more commonly than the other varieties (60 %, as against 20 % and 30 %).
In my small series, mucinous was the most common type of tumour, followed by endometrioid and then serous.
No obvious spread but bilateral ovarian enlargement was also commoner with the serous carcinomas (36%, as against 10% and 12%) and this is an example of multifocal origin of cancer with the simultaneous appearance of two primary carcinomas in a paired organ. Spread via the lymphatics does not seem to be a rational explanation.
The Uterus
If the uterus is not removed during treatment, it is essential to carry out curettage to exclude involvement of the endometrium. The only cases in which I have encountered such involvement have been those where it was not possible to decide which was the primary, the lesions being so similar. A large number of such cases have been reported also from Stockholm by Santesson & Kottmeier (1968) . Endometrioid carcinoma of the ovary occurred in 276 cases and 89 of these also showed carcinoma in the body of the uterus. It has been suggested that these endometrioid lesions arise in ovarian deposits of endometriosis. Their prognosis is relatively good: 50% survive five years.
There is no doubt that the other types ofovarian cancer may spread to the uterus, but the incidence is low (13T7%) and these show a 40 8% five-year survival rate, suggesting that the prognosis is not influenced unduly by extension to the uterus if this is treated adequately (Kottmeier 1968 ).
Other Aspects
(1) Removal of the omentum does not seem to have any part in the treatment, apart from palliation.
(2) Dysgerminomas behave in the same way as other carcinomas. I am grateful to L Brunello for details of his series of cases and a study of the literature.
(3) Exenteration is occasionally useful for recurrent disease in the centre of the pelvis; these patients are usually suffering from endometrioid type of carcinoma.
In summary, laparotomy is always necessary to make the diagnosis, but palliative removal of tumour is all that is possible in over 50%.
When definitive treatment can be considered in the younger woman, or when there is doubt about malignancy, local removal of the tumour (or ovary) is the treatment of choice followed by curettage to exclude spread to the uterus. The histological classification of the tumour is a useful guide to prognosis, which on the whole is good.
-Mucinous tumours are most common and endometrioid tumours have a prognosis very similar to carcinoma of the body, i.e. better than that usually found for ovarian carcinoma. My material is grouped according to anatomical stage and histological classification using, with slight modifications, the method suggested at the American Radium Society meeting in 1961 (Table 1) . At the Royal Marsden Hospital 371 cases of cystadenocarcinoma were seen between 1945 and 1965. Table 2 shows the number in each stage and the proportion of well-differentiated tumours. Only a small proportion of patients There is little disagreement that treatment should be mainly surgical, which may be followed by some variety of radiotherapy except in very early cases; the most commonly used is external radiation in order that the whole of the area involved in disease may be treated. Radium is useful if the uterus has been leftradioactive colloidal gold injected into the peritoneal cavity may be used in place of external radiation immediately post-operatively or reserved for the treatment of recurrent malignant ascites. Table 3 compares the results of treatment by surgery alone with surgery followed by radiotherapy. The two series cannot be directly compared but the main benefit of radiation appears to be to the poorly differentiated and anaplastic tumours. Table 4 shows the same material divided according to stage. In the 'surgery only' group are mainly patients in whom the disease was thought to have been completely removed. In the combined therapy group there are more patients with advanced tumours; nearly one-third of those with Stage III tumours survived three years.
Of course an operable tumour should be completely removed but it is more difficult to decide how much to remove of an inoperable one: removal of as much of the tumour as possible means cutting across lymphatics but does decrease the bulk of tumour to be irradiated. However, in this series results in Stage III related to the extent of surgery were inconclusive. Megavoltage therapy has virtually replaced orthovoltage buf the problems of the volume to be treated and dosage required remain the same. These tumours are not generally very radiosensitive and the larger the volume to be irradiated the smaller the dose that can be given. Since many ovarian tumours are sensitive to cytotoxic drugs it seems reasonable to substitute them for large field irradiation if the disease has spread outside the pelvis. Radiotherapy can then be reserved for more localized disease giving a dose of about 5,000 rads spread over four or five weeks. If the uterus is left in position it may be used as a radium container and this will give a high localized dose to the surrounding structures. However,-using megavoltage there is little problem in treating the pelvis adequately and it is probably an advantage to remove the uterus together with both ovaries. Certainly in this series the results seem to be slightly but definitely better if a hysterectomy has been done. On the other hand, if the uterus is left, then the results are improved when radium is inserted rather than leaving treatment to external radiation only. It must be noted, however, that it has been impossible retrospectively to estimate the percentage of cases where the uterus was healthy and where it was involved in the disease. The instillation of colloidal gold into the peritoneal cavity may control recurrent ascites for a few months but it is a purely palliative procedure and the same results may be more simply achieved by a similar use ofcytotoxic drugs.
Pseudomucinous cystadenocarcinoma was less common than cystadenocarcinoma but the prognosis appeared to be similar. Other tumours which occur in the ovary but show a completely different natural history and radiosensitivityare the granulosa cell tumours and the dysgerminomas. The former usually occur after the age of 40 years and are often associated with carcinoma corporis, have a long natural history and are quite radiosensitive; even when they recur they are not Section ofObstetrics and Gynecology 361 always immediately lethal but are worth treating with radiotherapy and patients may survive many years after treatment; 12 new cases and 11 recurrences were seen in this series. Dysgerminomas were less commononly 8 new cases being seen in the same period; they were younger but survival was quite good and showed that it may be a matter of years even after several recurrences.
A study of results related to duration of symptoms shows that, as with malignant disease in other sites, early diagnosis does not necessarily lead to improved cure rate. The five-year survival rate in patients with symptoms going back less than two months was 27% and even in the 3-8 months group, 22 %; when the delay was more than nine months, it was 24 %. In the first group in spite of the short history there was a large proportion of Stage III and IV cases, while in the group with a long history there was a surprising number of patients with early disease. The malignancy of the tumour is more important than the speed of the diagnosis.
As in other series the results became worse with increasing age. Table 5 gives the results of all stages and histological groups of the cystadenocarcinoma.
Although the results of the whole group are poor-24 % five-year survivalcertain types are not unfavourable. Patients with a well-differentiated tumour which has not penetrated the capsule show an 86 % five-year survival rate but such cases are rare. The main points of interest are the poor results with less well-differentiated tumours, even in the early stages, and the almost complete hopelessness of the prognosis once disease has spread outside the pelvis.
Professor Dr H G Limburg (Universitdtskliniken imLandeskrankenhaus, Homburg, Saar, Germany)
Chemotherapy in the Treatment of Ovarian Cancer
The varying reactions of human tumours of the female genitalia, especially of ovarian cancers, to modern cytostatic drugs were examined with the aid of primary tissue cultures in vitro. The cultivations are performed in a Leighton tube by means of the trypsinizing method (Dulbecco & Vogt 1954) . The total material evaluated to date includes more than 1,400 explanted human tissues, the success rate being 80%; in ovarian cancers 94%.
The primary cultures include normal squamous epithelium of the cervix, carcinoma-in-situ, cancer of the cervix and corpus, ovarian cancer and ovarian carcinoma ascites. With the aid of these tissue cultures examinations were carried out to observe the varying reactions of tumour cells to cytostatic drugs such as cyclophosphamide mitomen, methotrexate, methylhydrazin, SPI 77, thiothepa, triaziquone and vinblastine. Adapting the dosage of the chemotherapeutic substances in vitro to the actual conditions of the clinical treatment it has been possible in 300 cases to judge the probable efficacy of the substance. This 'cancer chemotherapy sensitivity test' shows completely different individual reactions from the completely resistant culture to the cytolytic destruction of the cell monolayer, although the tumour morphology may be equal or similar. By the test, one is in a position to apply an individually determined cytostatic therapy to every kind of tumour provided that at least one of the drugs is effective. The clinical results of selective chemotherapy of cancer of the female genitalia are demonstrated by the survival rates and clinical criteria of those treated as compared to those without selective chemotherapy. An accurate objective response index based on gross tumour regression is possible in patients previously receiving the TNM classification before definitive treatment. The T classification which is based as a rule on simple clinical examination is inappropriate. Accordingly TP, which takes into account the findings at operation, should be used following the recommendations of the International Union Against Cancer (UICC), Geneva 1966 (Kottmeier 1968 ).
In the patients under investigation the implantation of tumour masses or metastases were present within the peritoneal cavity including the omentum, small intestine, mesentery, liver or other viscera (Mlb) and in several cases outside the peritoneal cavity (Mlc).
